Physician profile
Allison Gardner
NPI 1528600707
$1,099.78
in general payments reported to CMS, 2019-2025
12 companies · $75.67 in 2025
The $75.67 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $577 · 2023: $321 · 2024: $126 · 2025: $75.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $243.40 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Shield Therapeutics INC | $164.53 | 2022-2023 | Accrufer |
| Vertos Medical, INC. | $138.96 | 2022 | |
| Abbvie INC. | $122.65 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $110.27 | 2024 | Ingrezza |
| Inari Medical, INC. | $97.58 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $80.84 | 2022-2024 | Farxiga |
| Globus Medical, INC. | $48.70 | 2025 | Senza |
| Lilly USA, LLC | $29.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.63 | 2022 | |
| Global Blood Therapeutics, INC. | $21.48 | 2022 | |
| Merck Sharp & Dohme LLC | $18.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.